The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Certolizumab Pegol Market Research Report 2025
Synopsis
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
The global Certolizumab Pegol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Certolizumab Pegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Certolizumab Pegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Certolizumab Pegol in Crohn’s disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Certolizumab Pegol include UCB. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Certolizumab Pegol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Certolizumab Pegol.
Report Scope
The Certolizumab Pegol market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Certolizumab Pegol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Certolizumab Pegol companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
UCB
Segment by Type
Single-dose vial
Single-dose prefilled syringe
Segment by Application
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Certolizumab Pegol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
The global Certolizumab Pegol market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Certolizumab Pegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Certolizumab Pegol is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Certolizumab Pegol in Crohn’s disease is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Certolizumab Pegol include UCB. etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Certolizumab Pegol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Certolizumab Pegol.
Report Scope
The Certolizumab Pegol market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Certolizumab Pegol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Certolizumab Pegol companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
UCB
Segment by Type
Single-dose vial
Single-dose prefilled syringe
Segment by Application
Crohn’s disease
Active rheumatoid arthritis
Active psoriatic arthritis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Certolizumab Pegol companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Certolizumab Pegol Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Single-dose vial
1.2.3 Single-dose prefilled syringe
1.3 Market by Application
1.3.1 Global Certolizumab Pegol Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Crohn’s disease
1.3.3 Active rheumatoid arthritis
1.3.4 Active psoriatic arthritis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Certolizumab Pegol Market Perspective (2019-2030)
2.2 Certolizumab Pegol Growth Trends by Region
2.2.1 Global Certolizumab Pegol Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Certolizumab Pegol Historic Market Size by Region (2019-2024)
2.2.3 Certolizumab Pegol Forecasted Market Size by Region (2025-2030)
2.3 Certolizumab Pegol Market Dynamics
2.3.1 Certolizumab Pegol Industry Trends
2.3.2 Certolizumab Pegol Market Drivers
2.3.3 Certolizumab Pegol Market Challenges
2.3.4 Certolizumab Pegol Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Certolizumab Pegol Players by Revenue
3.1.1 Global Top Certolizumab Pegol Players by Revenue (2019-2024)
3.1.2 Global Certolizumab Pegol Revenue Market Share by Players (2019-2024)
3.2 Global Certolizumab Pegol Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Certolizumab Pegol Revenue
3.4 Global Certolizumab Pegol Market Concentration Ratio
3.4.1 Global Certolizumab Pegol Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Certolizumab Pegol Revenue in 2023
3.5 Certolizumab Pegol Key Players Head office and Area Served
3.6 Key Players Certolizumab Pegol Product Solution and Service
3.7 Date of Enter into Certolizumab Pegol Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Certolizumab Pegol Breakdown Data by Type
4.1 Global Certolizumab Pegol Historic Market Size by Type (2019-2024)
4.2 Global Certolizumab Pegol Forecasted Market Size by Type (2025-2030)
5 Certolizumab Pegol Breakdown Data by Application
5.1 Global Certolizumab Pegol Historic Market Size by Application (2019-2024)
5.2 Global Certolizumab Pegol Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Certolizumab Pegol Market Size (2019-2030)
6.2 North America Certolizumab Pegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Certolizumab Pegol Market Size by Country (2019-2024)
6.4 North America Certolizumab Pegol Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Certolizumab Pegol Market Size (2019-2030)
7.2 Europe Certolizumab Pegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Certolizumab Pegol Market Size by Country (2019-2024)
7.4 Europe Certolizumab Pegol Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Certolizumab Pegol Market Size (2019-2030)
8.2 Asia-Pacific Certolizumab Pegol Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Certolizumab Pegol Market Size by Region (2019-2024)
8.4 Asia-Pacific Certolizumab Pegol Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Certolizumab Pegol Market Size (2019-2030)
9.2 Latin America Certolizumab Pegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Certolizumab Pegol Market Size by Country (2019-2024)
9.4 Latin America Certolizumab Pegol Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Certolizumab Pegol Market Size (2019-2030)
10.2 Middle East & Africa Certolizumab Pegol Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Certolizumab Pegol Market Size by Country (2019-2024)
10.4 Middle East & Africa Certolizumab Pegol Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 UCB
11.1.1 UCB Company Detail
11.1.2 UCB Business Overview
11.1.3 UCB Certolizumab Pegol Introduction
11.1.4 UCB Revenue in Certolizumab Pegol Business (2019-2024)
11.1.5 UCB Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Certolizumab Pegol Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Single-dose vial
Table 3. Key Players of Single-dose prefilled syringe
Table 4. Global Certolizumab Pegol Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Certolizumab Pegol Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Certolizumab Pegol Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Certolizumab Pegol Market Share by Region (2019-2024)
Table 8. Global Certolizumab Pegol Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Certolizumab Pegol Market Share by Region (2025-2030)
Table 10. Certolizumab Pegol Market Trends
Table 11. Certolizumab Pegol Market Drivers
Table 12. Certolizumab Pegol Market Challenges
Table 13. Certolizumab Pegol Market Restraints
Table 14. Global Certolizumab Pegol Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Certolizumab Pegol Market Share by Players (2019-2024)
Table 16. Global Top Certolizumab Pegol Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Certolizumab Pegol as of 2023)
Table 17. Ranking of Global Top Certolizumab Pegol Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Certolizumab Pegol Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Certolizumab Pegol Product Solution and Service
Table 21. Date of Enter into Certolizumab Pegol Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Certolizumab Pegol Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Certolizumab Pegol Revenue Market Share by Type (2019-2024)
Table 25. Global Certolizumab Pegol Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Certolizumab Pegol Revenue Market Share by Type (2025-2030)
Table 27. Global Certolizumab Pegol Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Certolizumab Pegol Revenue Market Share by Application (2019-2024)
Table 29. Global Certolizumab Pegol Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Certolizumab Pegol Revenue Market Share by Application (2025-2030)
Table 31. North America Certolizumab Pegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Certolizumab Pegol Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Certolizumab Pegol Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Certolizumab Pegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Certolizumab Pegol Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Certolizumab Pegol Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Certolizumab Pegol Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Certolizumab Pegol Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Certolizumab Pegol Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Certolizumab Pegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Certolizumab Pegol Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Certolizumab Pegol Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Certolizumab Pegol Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Certolizumab Pegol Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Certolizumab Pegol Market Size by Country (2025-2030) & (US$ Million)
Table 46. UCB Company Detail
Table 47. UCB Business Overview
Table 48. UCB Certolizumab Pegol Product
Table 49. UCB Revenue in Certolizumab Pegol Business (2019-2024) & (US$ Million)
Table 50. UCB Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Certolizumab Pegol Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Certolizumab Pegol Market Share by Type: 2023 VS 2030
Figure 3. Single-dose vial Features
Figure 4. Single-dose prefilled syringe Features
Figure 5. Global Certolizumab Pegol Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Certolizumab Pegol Market Share by Application: 2023 VS 2030
Figure 7. Crohn’s disease Case Studies
Figure 8. Active rheumatoid arthritis Case Studies
Figure 9. Active psoriatic arthritis Case Studies
Figure 10. Certolizumab Pegol Report Years Considered
Figure 11. Global Certolizumab Pegol Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Certolizumab Pegol Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Certolizumab Pegol Market Share by Region: 2023 VS 2030
Figure 14. Global Certolizumab Pegol Market Share by Players in 2023
Figure 15. Global Top Certolizumab Pegol Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Certolizumab Pegol as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Certolizumab Pegol Revenue in 2023
Figure 17. North America Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Certolizumab Pegol Market Share by Country (2019-2030)
Figure 19. United States Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Certolizumab Pegol Market Share by Country (2019-2030)
Figure 23. Germany Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Certolizumab Pegol Market Share by Region (2019-2030)
Figure 31. China Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Certolizumab Pegol Market Share by Country (2019-2030)
Figure 39. Mexico Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Certolizumab Pegol Market Share by Country (2019-2030)
Figure 43. Turkey Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Certolizumab Pegol Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. UCB Revenue Growth Rate in Certolizumab Pegol Business (2019-2024)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
